Senescent fibroblasts are aging cells that no longer divide and protect against tumor development. Yet two decades have gone ...

DELFI Diagnostics, Inc., developer of accessible blood-based, liquid biopsy tests that deliver a new way to enhance early cancer detection, announced that researchers from NYU Langone Health, in ...

The FDA granted traditional approval to pirtobrutinib (Jaypirca) for relapsed/refractory chronic lymphocytic leukemia/small ...

Squamous cell carcinoma treatment varies by stage, involving surgery, radiation, and systemic therapies based on cancer ...

Dr. Girindra Raval sat down for an interview with CURE to discuss what patients with EGFR-mutated lung cancer should know about their treatment options, highlighting the latest advancements in ...

Elevar plans resubmission of a New Drug Application to the U.S. Food and Drug Administration for the combination therapy of camrelizumab and rivoceranib in January 2026.

The companies plan to test the treatment's efficacy in preclinical models of squamous cell lung carcinoma early next year.

A new program launched by UR Medicine primary care in 2022 has helped more than double lung screening rates. A recent study ...

Senescent fibroblasts are aging cells that no longer divide and protect against tumor development. Yet two decades have gone ...

CorriXR Therapeutics, an oncology-focused biotherapeutics company pioneering a ground-breaking gene editing platform technology, InhaTarget Therapeutics, a company dedicated to the early development ...

Full House' star Dave Coulier enters another cancer battle mere months after beating non-Hodgkin lymphoma. 'Totally unrelated ...

By the age of nine, he had been diagnosed with cancer and had had his left lung removed. For him and his family, it was a ...